These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS? Kang BJ, Cho MJ, Oh JT, Lee Y, Chae BJ, Ko J. Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201 [Abstract] [Full Text] [Related]
27. [A case study; ethnicity and clozapine, a risky combination?]. Laan WJ, Ramlal D. Tijdschr Psychiatr; 2012 Mar; 54(9):829-33. PubMed ID: 22961282 [Abstract] [Full Text] [Related]
28. Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use. Remington G, Lee J, Agid O, Takeuchi H, Foussias G, Hahn M, Fervaha G, Burton L, Powell V. Expert Opin Drug Saf; 2016 Sep; 15(9):1193-203. PubMed ID: 27207070 [Abstract] [Full Text] [Related]
29. FDA changes clozapine monitoring guidelines: Implications for worldwide practice. Bastiampillai T, Gupta A, Allison S. Asian J Psychiatr; 2016 Jun; 21():19-20. PubMed ID: 27208449 [Abstract] [Full Text] [Related]
31. Quetiapine XR-induced neutropenia: is a clozapine trial still possible for treatment-resistant schizophrenia? A case report. Crépeau-Gendron G, L'Heureux S. Early Interv Psychiatry; 2015 Apr; 9(2):151-5. PubMed ID: 24690066 [Abstract] [Full Text] [Related]
32. [Hematological Evaluation and Monitoring in Adult Patients Diagnosed With Schizophrenia]. Tamayo Martínez N, Bohórquez Peñaranda AP, García Valencia J, Jaramillo González LE, Ávila MJ, Gómez-Restrepo C, Arenas González ML. Rev Colomb Psiquiatr; 2015 Apr; 44(3):131-6. PubMed ID: 26578412 [Abstract] [Full Text] [Related]
33. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. Alvir JM, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA. N Engl J Med; 1993 Jul 15; 329(3):162-7. PubMed ID: 8515788 [Abstract] [Full Text] [Related]
34. Clozapine alone versus clozapine and risperidone for refractory schizophrenia. Gerson SL. N Engl J Med; 2006 Apr 27; 354(17):1846-8; author reply 1846-8. PubMed ID: 16642587 [No Abstract] [Full Text] [Related]
39. FDA approves clozapine for treatment of schizophrenia; careful monitoring required. Hosp Community Psychiatry; 1989 Dec 27; 40(12):1310. PubMed ID: 2591894 [No Abstract] [Full Text] [Related]
40. Clozapine-lithium combined treatment and agranulocytosis. Valevski A, Modai I, Lahav M, Weizman A. Int Clin Psychopharmacol; 1993 Dec 27; 8(1):63-5. PubMed ID: 8473724 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]